[go: up one dir, main page]

HUP0000397A2 - Minimális szisztémás hatású glukokortikoidok alkalmazása ízületi gyulladás kezelésére szolgáló gyógyszerkészítmények előállítására - Google Patents

Minimális szisztémás hatású glukokortikoidok alkalmazása ízületi gyulladás kezelésére szolgáló gyógyszerkészítmények előállítására

Info

Publication number
HUP0000397A2
HUP0000397A2 HU0000397A HUP0000397A HUP0000397A2 HU P0000397 A2 HUP0000397 A2 HU P0000397A2 HU 0000397 A HU0000397 A HU 0000397A HU P0000397 A HUP0000397 A HU P0000397A HU P0000397 A2 HUP0000397 A2 HU P0000397A2
Authority
HU
Hungary
Prior art keywords
treatment
pasessing
glucocorticoid
substances
pharmaceutical composition
Prior art date
Application number
HU0000397A
Other languages
English (en)
Inventor
Roger Hällgren
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of HUP0000397A2 publication Critical patent/HUP0000397A2/hu
Publication of HUP0000397A3 publication Critical patent/HUP0000397A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány tárgya minimális szisztémás hatású glukokortikoidokalkalmazása orális vagy rektális beadásra szánt, nem helyi használatraszánt, ízületi gyulladás kezelésére szolgáló, gyógyszerkészítményekelőállítására. Ó
HU0000397A 1996-12-20 1997-12-16 The use of glucocorticoid substances pasessing a minimal systemic effect for producing pharmaceutical composition for the treatment of joint inflammation HUP0000397A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9604751A SE9604751D0 (sv) 1996-12-20 1996-12-20 New therapy
PCT/SE1997/002124 WO1998027987A1 (en) 1996-12-20 1997-12-16 New treatment for joint inflammation

Publications (2)

Publication Number Publication Date
HUP0000397A2 true HUP0000397A2 (hu) 2000-10-28
HUP0000397A3 HUP0000397A3 (en) 2001-01-29

Family

ID=20405107

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000397A HUP0000397A3 (en) 1996-12-20 1997-12-16 The use of glucocorticoid substances pasessing a minimal systemic effect for producing pharmaceutical composition for the treatment of joint inflammation

Country Status (20)

Country Link
US (1) US6432937B1 (hu)
EP (1) EP0957922A1 (hu)
JP (1) JP2001507024A (hu)
KR (1) KR20000069594A (hu)
AU (1) AU5502598A (hu)
BR (1) BR9713975A (hu)
CA (1) CA2274769A1 (hu)
CZ (1) CZ219399A3 (hu)
EE (1) EE9900258A (hu)
HU (1) HUP0000397A3 (hu)
ID (1) ID21763A (hu)
IL (1) IL130485A0 (hu)
IS (1) IS5056A (hu)
NO (1) NO993066L (hu)
NZ (1) NZ336025A (hu)
PL (1) PL334012A1 (hu)
SE (1) SE9604751D0 (hu)
SK (1) SK82699A3 (hu)
TR (1) TR199901413T2 (hu)
WO (1) WO1998027987A1 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2101819B1 (en) 2006-11-20 2013-01-09 President and Fellows of Harvard College Methods, compositions, and kits for treating pain and pruritis
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
JP6205133B2 (ja) 2009-07-10 2017-09-27 プレジデント アンド フェローズ オブ ハーバード カレッジ 抗炎症剤としての恒久的に荷電したナトリウムおよびカルシウムチャンネルブロッカー
WO2011032175A1 (en) 2009-09-14 2011-03-17 Nuon Therapeutics, Inc. Combination formulations of tranilast and allopurinol and methods related thereto
WO2012112969A1 (en) 2011-02-18 2012-08-23 Endo Pharmaceuticals Inc. Aminoindane compounds and use thereof in treating pain
EP2771320B1 (en) 2011-10-24 2016-06-22 Endo Pharmaceuticals Inc. Cyclohexylamines
KR20220112867A (ko) 2013-12-16 2022-08-11 에이비에스 디벨롭먼트 원 인코포레이티드 P2x3 및/또는 p2x2/3 화합물 및 방법
WO2017024037A1 (en) 2015-08-03 2017-02-09 President And Fellows Of Harvard College Charged ion channel blockers and methods for use
JP2016193937A (ja) * 2016-08-09 2016-11-17 株式会社エヌ・エル・エー 関節痛緩和組成物および機能性食品、並びに発酵ショウガ及びその製造方法
WO2018064135A1 (en) 2016-09-30 2018-04-05 Asana Biosciences, Llc P2x3 and/or p2x2/3 compounds and methods
CN113811305A (zh) 2019-03-11 2021-12-17 诺西恩医疗公司 带电的离子通道阻滞剂及其使用方法
JP7630439B2 (ja) 2019-03-11 2025-02-17 ノシオン セラピューティクス，インコーポレイテッド エステル置換イオンチャンネル遮断薬および使用方法
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10968179B2 (en) 2019-03-11 2021-04-06 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10933055B1 (en) 2019-11-06 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
MX2022005335A (es) 2019-11-06 2022-08-17 Nocion Therapeutics Inc Bloqueadores de canales ionicos cargados y metodos de uso.
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
WO2021183639A1 (en) 2020-03-11 2021-09-16 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
CA2140660A1 (en) * 1993-06-13 1994-12-22 Uwe R. Juergens Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system

Also Published As

Publication number Publication date
EP0957922A1 (en) 1999-11-24
WO1998027987A1 (en) 1998-07-02
TR199901413T2 (xx) 1999-08-23
US6432937B1 (en) 2002-08-13
BR9713975A (pt) 2000-04-11
SE9604751D0 (sv) 1996-12-20
AU5502598A (en) 1998-07-17
NO993066D0 (no) 1999-06-21
JP2001507024A (ja) 2001-05-29
CZ219399A3 (cs) 1999-09-15
IS5056A (is) 1999-05-27
NZ336025A (en) 2001-02-23
CA2274769A1 (en) 1998-07-02
KR20000069594A (ko) 2000-11-25
ID21763A (id) 1999-07-22
HUP0000397A3 (en) 2001-01-29
EE9900258A (et) 1999-12-15
IL130485A0 (en) 2000-06-01
NO993066L (no) 1999-06-21
PL334012A1 (en) 2000-01-31
SK82699A3 (en) 2000-02-14

Similar Documents

Publication Publication Date Title
HUP0000397A2 (hu) Minimális szisztémás hatású glukokortikoidok alkalmazása ízületi gyulladás kezelésére szolgáló gyógyszerkészítmények előállítására
CY1105225T1 (el) Παραγωγα 5-β-σαπωγενινης και ψευδοσαπωγενινης και η χρηση τους στην αντιμετωπιση ανοιας
BR1100860A (pt) Composto, droga antiinflamatória, composição farmacêutica, epìmero r e epìmero s do composto
AU2386201A (en) Substituted sapogenins and their use
ATE238773T1 (de) Arzneimittel für die kombination piperidinoalkanol-dekongestivum
ES2187201T3 (es) Empleo de esteroles y de esterolesteres a nanoescala.
ES8801785A1 (es) Un procedimiento para la preparacion de nuevas azetidinonas sustituidas.
AU6666096A (en) Pharmaceutical composition containing il-10
DK0873351T3 (da) Steroidnitrit/nitratesterderivater anvendelige som antiinflammatoriske lægemidler
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
EP0821587A4 (en) COMPOSITIONS, KITS AND METHODS FOR ADMINISTERING ANTILIPEMICS AND MEDICINES AGAINST PLATELET AGGREGATION
NO20015790D0 (no) Androstenderivater
NO991405L (no) Belagt partikkelformulering
IT1285770B1 (it) Composti corticoidei
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
HUP0004544A2 (hu) Angiotenzin-átalakító enzim inhibitora és diuretikum kombinációjának alkalmazása mikrokeringési rendellenességek kezelésére szolgáló gyógyászati készítmény előállítására
ATE53376T1 (de) Entzuendungshemmende agentien.
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
ATE375359T1 (de) Aminosterolderivate und ihre verwendungen
ATE360428T1 (de) Analgetisches arzneimittel
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
AU6206486A (en) P-acylaminobenzamides
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration